Health Benefits at a Glance:
Super R-Lipoic Acid is truly unique antioxidant that not only protects the cells against free radicals but also supports energy production in the cells at the same time. This means that Super R-Lipoic Acid both allows cells to produce energy and function under better-than-normal conditions, providing your body with the energy it needs while protecting the cells for better cell function throughout the body.
Why it Works:
Studies have shown the critical role that lipoic acid plays in preserving youthful cellular energy by supporting healthy mitochondrial function.
Lipoic acid takes two forms (isomers). The R form is made by your body and the S form is chemically produced. Pure R-lipoic acid contained in Super R-Lipoic Acid is more potent than a combination of the two forms, which conventional alpha-lipoic acid supplements typically contain.
And unlike other forms of lipoic acid, the sodium lipoate in Super R-Lipoic Acid is more stable in the body. The increased stability of this enhanced formulation is the reason for its greater absorption and bioavailability compared with R-lipoic acid.Super R-Lipoic Acid provides only the "R" form of lipoic acid, meaning that it can better help protect your cells while supporting cellular energy production than ordinary lipoic acid antioxidants.
Although antioxidants are great for protecting the cells against free radicals, they are not known to support cellular energy production. Super R-Lipoic Acid is therefore truly revolutionizing because it is both a potent antioxidant which also supports healthy mitochondrial function. Unlike many other forms of lipoic acid, the unique Super R-Lipoic Acid is more bioavailable, stable, and potent than pure R-Lipoic Acid. Achieving 10–30 times higher peak blood levels than conventional R- lipoic acid [1-11], this is truly an out-of-the-ordinary antioxidant.
The Science Behind the Product:
The R form of lipoic acid (isomer) is made by your body and the S form is chemically produced. Alpha-lipoic acid is an antioxidant which consists of two different forms of isomers (R and S) have greatly different properties. The “R” form is the biologically active component that is amenable for lipoic acid’s phenomenal antioxidant effect. The “S” form is produced from chemical manufacture.
Alpha-lipoic acid supplements typically consist of the "R" and "S" form in a 50/50 ratio.
The "R" form of lipoic acid is normally produced and used by the human body. R-lipoic acid plays a role in, scavenging free radicals. Furthermore, it has been shown that “R” form of lipoic acid is more potent than the combined "R" and "S" forms that ordinarily comprise alpha-lipoic acid supplements [1-11].
Research has however indicated that a newer form of R-lipoic acid has been found. This sodium-R-lipoate can be seen as the "next-generation" antioxidant powerhouse. R-lipoic acid already has shown better bioavailability, stability, and provide a vast majority of health benefits.
It was shown that the newer lipoic acid formulation reached higher peak blood levels  and it also achieves them sooner, assuring rapid uptake from the plasma into the tissues . One study reported that oral ingestion of Super R-Lipoic Acid, after converting to sodium-R-lipoate, reached peak plasma concentrations within just 10–20 minutes of supplementation .
How to Use:
- Take one (1) to two (2) capsules daily as tolerated, or as recommended by a healthcare practitioner.
- Take capsules at the same time, preferably on an empty stomach.
- Suitable for vegetarians.
Read original source
- Pharmacol Res. 2011 Jan;63(1):23-9.
- Ann N Y Acad Sci. 2010 Aug;1203:151-9.
- Wien Klin Wochenschr. 2006 Mar;118(3-4):100-7.
- Free Radic Res. 2004 Oct;38(10):1083-92.
- Nutrition. 2001 Oct;17(10):888-95.
- Adv Drug Deliv Rev. 2008 Oct-Nov;60(13-14):1463-70.
- Arch Pharm (Weinheim). 2010 Mar;343(3):133-42.
- Metabolism. 2008 Oct;57(10):1465-72.
- Brain Res. 2000 Feb 14;855(2):292-7.
- Ann N Y Acad Sci. 2002 Apr;959:491-507.
- Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R587-97.
- Altern Med Rev. 2007 Dec;12(4):343-51.